Surgeon Experience Influences Post-Op Mobilization Orders

Share this content:
Surgeon Experience Influences Post-Op Mobilization Orders
Surgeon Experience Influences Post-Op Mobilization Orders

FRIDAY, Oct. 21, 2016 (HealthDay News) -- Patient characteristics and surgeon factors influence surgeons' postoperative weight-bearing orders after hip fracture repair, according to research published online Oct. 6 in the Journal of Evaluation in Clinical Practice.

Leslie Carlin, Ph.D., from the University of Toronto Faculty of Medicine, and colleagues interviewed 20 orthopedic surgeons across Canada who perform hip fracture repair surgery to examine their attitudes and behavior toward patient management for weight bearing.

The researchers found that both patient characteristics and surgeon factors influenced surgeons' postoperative weight-bearing orders. Almost all patients agreed that weight bearing as tolerated was therapeutic for most hip fracture repair or replacement patients, while surgeons described specific patient characteristics that would reduce the value of immediate weight bearing. These included poor bone quality and specific fracture patterns. Choice of construct, previous experience of construct failure, and lack of local audit data relating to weight-bearing decisions and patient outcomes were surgeon factors that affected postoperative mobilization orders.

"Thus, although familiar with best practice guidelines, surgeons also have 'rules to break the rules,'" the authors write. "In an era when 'good' medicine leans toward science rather than art, the role of individual experience in decision making with regard to hip fracture care continues to be important and would benefit from being discussed open."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »